by Biotechnology Focus •
February 12, 2016 •
Business Focus, Deals/M&A/Collaboration •
Comments (0) •
Milton, ON -Stockholders of POZEN and shareholders of Tribute Pharmaceuticals Canada have approved a transaction merging the two companies.
Comments are closed.
© 2017 Biotechnology Focus™
Powered by Wordpress. Designed by Themnific™